Using a large cohort of men gathered from across the United Kingdom over a period of more than 15 years, Hsp-27 expression was used to accurately segregate men with poor prognosis of prostate cancer and who required active treatment from those with relatively indolent disease that could be managed conservatively, with confidence. Here, HSPB1 is linked to prostate cancer.